Medical technology firm Lifeward Ltd. (LFWD) announced Thursday that it has received 510(k) FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7.
The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury (SCI) to stand and walk again, includes a number of new features, as well as enhancements and upgrades.
Lifeward will begin sales of the ReWalk 7 in the United States as soon as the product is available.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.